Emerging Sub-Segments Transforming the Pharmacovigilance Market Landscape

The pharmacovigilance sector is set for significant expansion as the healthcare industry increasingly emphasizes drug safety and patient outcomes. With advancements in technology and regulatory frameworks evolving worldwide, the market is poised to reach remarkable heights over the coming years. Below, we explore the market's value projections, key players, emerging trends, and detailed segment breakdowns shaping the future of pharmacovigilance.

Pharmacovigilance Market Size Forecast Through 2030
The pharmacovigilance market is on track for rapid growth, projected to reach $17.41 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 12.5% during the forecast period. The surge can be largely attributed to increasing use of real-world data, a rise in approvals of biologics and biosimilars, growing complexity in combination therapies, expansion into emerging markets, and a heightened focus on patient safety outcomes. Notable trends driving this momentum include the broadening scope of post-marketing surveillance, widespread adoption of real-world evidence to monitor safety, stricter regulatory oversight, an increase in outsourcing pharmacovigilance services, and the integration of multisource safety data platforms.

Download a free sample of the pharmacovigilance market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Prominent Companies Leading the Pharmacovigilance Industry
A number of influential organizations dominate the pharmacovigilance landscape, including IQVIA, Cognizant, ICON Plc, accenture* plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc., QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, and Telerx Marketing Inc.
In a notable development in January 2023, AmerisourceBergen, a leading American drug wholesaler, acquired Pharma Lex, a Germany-based company, for an undisclosed sum. This acquisition is expected to strengthen AmerisourceBergen's portfolio by enhancing its offerings to pharmaceutical and biotech firms, providing comprehensive support throughout the product lifecycle. Pharma Lex specializes in end-to-end pharmacovigilance system operations and benefit-risk management services, adding considerable value to the parent company's capabilities.

Significant Trends Shaping the Pharmacovigilance Industry
Artificial intelligence (AI) is increasingly becoming a major focus within the pharmacovigilance sector as companies seek to boost efficiency and accuracy. Leveraging AI allows pharmaceutical firms to streamline pharmacovigilance workflows, enhance data management, accelerate drug development, and reduce operational costs while improving patient safety.
A prime example of these advancements is the launch of the Adverse Drug Reaction Monitoring System (ADRMS) software by the Government of India in August 2024. Unveiled by the Minister of Health & Family Welfare and the Minister of Chemicals and Fertilizers, this platform simplifies the reporting and analysis of adverse events related to medicines and medical devices for both healthcare professionals and consumers. The ADRMS significantly upgrades India's pharmacovigilance infrastructure by improving the comprehensiveness of safety data capture and drug safety monitoring, bolstering the country's position in the global pharmaceutical arena.

View the full pharmacovigilance market report:
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Breakdown of Key Pharmacovigilance Market Segments
The pharmacovigilance market is categorized into several segments based on different criteria:
1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining.
2) By Service Provider: In-House Services and Contract Outsourcing.
3) By Process Flow: Case Data Management, Signal Detection, and Risk Management Systems.
4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, and Phase IV.
5) By End User: Hospitals, Pharmaceutical Companies, and other users.

Further subsegment details include:
- Within Spontaneous Reporting, categories such as Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, and Case Reports from Healthcare Professionals.
- Intensified ADR Reporting covers Active Surveillance Programs, Enhanced Monitoring in Clinical Trials, and Risk Minimization Strategies.
- Targeted Spontaneous Reporting focuses on reporting for specific drug classes, condition-specific reporting, and focused surveillance initiatives.
- Cohort Event Monitoring includes Prospective Cohort Studies, Retrospective Cohort Studies, and Longitudinal Studies.
- EHR Mining involves data extraction from electronic health records, signal detection through EHR analysis, and integration of EHR data with pharmacovigilance systems.

This detailed segmentation provides a comprehensive view of the pharmacovigilance market's structure, highlighting the various approaches and services that contribute to drug safety monitoring worldwide.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.